Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.
Also called NCT04502017
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 360 participants
- Registry
-
NCT04502017
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT04502017. Randomized; no masking; primary purpose prevention. Start 2020-08-05 (actual); primary completion 2022-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
- Acronym
- FADE-DRT
- Condition
- Device-Related Thrombosis
- Condition
- Atrial Fibrillation
- Condition
- Left Atrial Appendage Occlusion
- Intervention (Drug)
- ASA plus Clopidogrel
- Intervention (Drug)
- Genetic-Tailored AntiThrombotic Strategy
- Intervention (Drug)
- Half-Dose of novel OAC
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
Record details
- Record id
cardio:ct-nct04502017- Content hash
04b9868a143620d8b523ea80df2551a8ff278970ae790f9a56e408585b4b99d0